Herein, we compare and contrast the efficacy of Ldlr-ASO and the Ldlr−/− mouse to silence the Ldlr, promote hypercholesterolemia, and facilitate atherosclerosis development in both male and female mice. The gene discussed is LDLR; the disease is familial hypercholesterolemia.